These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6686219)

  • 1. Roles of thromboxanes in gastrointestinal physiopathology.
    Bennett TA
    Int J Tissue React; 1983; 5(3):237-9. PubMed ID: 6686219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tripeptide ZAMI-420 inhibits thromboxane-induced gastric vasoconstriction and ischaemia.
    Moroni D; Gervasi GB; Patella P; Visentin L; Maselli MA; Bergamaschi M
    Int J Tissue React; 1983; 5(3):249-52. PubMed ID: 6654624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.
    Moncada S; Vane JR
    Pharmacol Rev; 1978 Sep; 30(3):293-331. PubMed ID: 116251
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I; Block HU; Mest HJ
    Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis and biological properties of prostaglandin endoperoxides and thromboxane A2.
    Svensson J
    Acta Biol Med Ger; 1978; 37(5-6):731-40. PubMed ID: 742285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R; Nenci GG; Gresele P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.
    Coleman RA; Humphrey PP; Kennedy I; Levy GP; Lumley P
    Br J Pharmacol; 1981 Jul; 73(3):773-8. PubMed ID: 7248665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy.
    Horn EH; Hardy E; Cooper J; Heptinstall S; Rubin PC
    Thromb Haemost; 1996 Feb; 75(2):346-51. PubMed ID: 8815588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboxane A2 and the endoperoxides mediate canine platelet activation.
    Harris RH; Nichols R; Schmeling JW; Ramwell PW
    Thromb Res; 1981 Sep; 23(6):521-32. PubMed ID: 6798707
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary vascular responses to thromboxane A2 as unmasked by OKY-1581. A novel inhibitor of thromboxane synthesis.
    Kadowitz PJ; Nandiwada PA; Spannhake EW; Rosenson RS; McNamara DB; Hyman AL
    Chest; 1983 May; 83(5 Suppl):72S-74S. PubMed ID: 6404609
    [No Abstract]   [Full Text] [Related]  

  • 11. Thromboxane agonism and antagonism in a mouse sudden death model.
    Myers A; Penhos J; Ramey E; Ramwell P
    J Pharmacol Exp Ther; 1983 Feb; 224(2):369-72. PubMed ID: 6822961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of thromboxane A2 in bradykinin-induced human isolated small bronchi contraction.
    Molimard M; Martin CA; Naline E; Hirsch A; Advenier C
    Eur J Pharmacol; 1995 May; 278(1):49-54. PubMed ID: 7545124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thromboxane A2-like activity of 11-fluoro-11-deoxyprostaglandin F2alpha in isolated smooth muscles].
    Nigamatov IM; Serkov IV; Gafurov RG; Bezuglov VV; Bergel'son LD
    Dokl Akad Nauk SSSR; 1986; 288(2):507-9. PubMed ID: 3720506
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of the prostaglandin H2/thromboxane A2 antagonist BM 13.177 on human platelets.
    Patscheke H; Stegmeier K
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():371-3. PubMed ID: 3159225
    [No Abstract]   [Full Text] [Related]  

  • 15. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of the stable thromboxane A2-mimetic, U46619, on gastric mucosal damage and gastric non-parietal secretion in the rat.
    Bunce KT; Clayton NM
    Br J Pharmacol; 1987 May; 91(1):23-9. PubMed ID: 3594079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different sensitivity of basilar and saphenous arteries to thromboxane A2-induced contractions. Effect of imidazole 2-hydroxybenzoate (ITF 182).
    Pagella PG; Agozzino S; Bellavite O; Donà GC; Mendola N
    Arzneimittelforschung; 1984; 34(11):1514-6. PubMed ID: 6596952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of pressor prostanoids in rats with angiotensin II-salt-induced hypertension.
    Mistry M; Nasjletti A
    Hypertension; 1988 Jun; 11(6 Pt 2):758-62. PubMed ID: 3164706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric mucosal erosion due to a mucosal ischemia produced by thromboxane A2-like substance in rats under water-immersion stress.
    Kitagawa H; Kurahashi K; Fujiwara M
    J Pharmacol Exp Ther; 1986 Apr; 237(1):300-4. PubMed ID: 2937910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 9, 11-Azo-12-oxa-15-hydroxyprostanoic acid: a potent thromboxane synthetase inhibitor and a PGH2/TxA2 receptor antagonist.
    Kam ST; Portoghese PS
    Prostaglandins Med; 1979 Nov; 3(5):279-90. PubMed ID: 233035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.